EYREIDA Eye drops, solution Ref.[49995] Active ingredients: Bimatoprost

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2022  Publisher: Aspire Pharma Ltd, Unit 4, Rotherbrook Court, Bedford Road, Petersfield, Hampshire, GU32 3QG, UK

Product name and form

Eyreida 0.3mg/ml eye drops, solution.

Pharmaceutical Form

Eye drops, solution.

Clear, colourless, eye drops.

Osmolality: 261-319 mOsm/Kg

pH: 6.8–7.8.

Qualitative and quantitative composition

1 ml of solution contains 0.3mg of bimatoprost.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Bimatoprost

Bimatoprost is a potent ocular hypotensive agent. It is a synthetic prostamide, structurally related to prostaglandin F (PGF), that does not act through any known prostaglandin receptors.

List of Excipients

Sodium chloride
Disodium hydrogen phosphate heptahydrate
Citric acid monohydrate
Sodium hydroxide or hydrochloric acid (for pH adjustment)
Water for injection

Pack sizes and marketing

Eyreida is presented as a clear, colorless aqueous solution in a white opaque 5 ml LDPE bottle and white Novelia nozzle (HDPE and silicone) and sealed with a white HDPE cap.

The following pack sizes are available: cartons containing 1 or 3 bottles of 3 ml solution.

Not all pack sizes may be marketed.

Marketing authorization holder

Aspire Pharma Ltd, Unit 4, Rotherbrook Court, Bedford Road, Petersfield, Hampshire, GU32 3QG, UK

Marketing authorization dates and numbers

PL35533/0107

Date of first authorisation: 18/12/2017

Drugs

Drug Countries
EYREIDA Ireland, United Kingdom

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.